OR WAIT null SECS
November 02, 2016
Astellas will acquire Ganymed and its portfolio of ideal monoclonal antibody candidates.
October 12, 2016
Piramal entered into an agreement with Janssen Pharmaceuticals to acquire five of the company’s injectable products.
October 05, 2016
Constantia Flexibles acquired a flexible packaging business from Lamp San Prospero SPA.
September 14, 2016
Allergan will acquire Vitae pharmaceuticals for $639 million.
September 01, 2016
CSafe completed the acquisition of Kallibox, a manufacturer of cold-chain packaging solutions.
August 16, 2016
Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.
August 10, 2016
BMS will reacquire the rights to ASLAN002 (BMS777607) from ASLAN Pharmaceuticals in China, Australia, Korea, Taiwan, and other Asian territories.
July 05, 2016
The acquisition will give Bristol-Myers Squibb full rights to Cormorant’s HuMax-IL8 antibody program.
June 13, 2016
Merck will acquire Afferent Pharmaceuticals for $500 million in cash with the potential for additional payments.
May 31, 2016
Jazz will acquire Celator for approximately $1.5 billion.